Evidence map›Paper›PMID 34890284›Full record

ArticleVector borne and zoonotic diseases (Larchmont, N.Y.)2022

SARS-CoV-2 Neutralizing Antibodies in White-Tailed Deer from Texas.

Pedro M Palermo, Jeanette Orbegozo, Douglas M Watts, John C Morrill

Open access · hybridAbstract read
In one paragraph

Article in Vector borne and zoonotic diseases (Larchmont, N.Y.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Evidence of SARS-CoV-2 Antibody in Mississippi White-Tailed Deer.Vector borne and zoonotic diseases (Larchmont, N.Y.) · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Pedro M PalermoDepartment of Biological Sciences, Border Biomedical Research Center, University of Texas at El Paso, El Paso, Texas, USA.ORCID 0000-0002-7471-0801
Jeanette OrbegozoDepartment of Biological Sciences, Border Biomedical Research Center, University of Texas at El Paso, El Paso, Texas, USA.
Douglas M WattsDepartment of Biological Sciences, Border Biomedical Research Center, University of Texas at El Paso, El Paso, Texas, USA.
John C MorrillOrion Research and Management Services, Gatesville, Texas, USA.
The University of Texas at El Paso · USOrion Corporation (United Kingdom) · GB

Funding

UTEP Border Biomedical Research CenterU54MD007592 · NIMHD · UNIVERSITY OF TEXAS EL PASO · PI Gabriel Andrew Frietze · 2019 to 2026
$35.1M
NIMHD NIH HHS U54 MD007592
6 · The paper itself

Abstract

Serological evidence of SARS-CoV-2 infection among white-tailed deer has been reported from Illinois, Michigan, Pennsylvania, and New York. This study was conducted to determine whether deer in Texas also had evidence of SARS-CoV-2 infection. Archived sera samples collected from deer in Travis County, Texas, during 2018, before and during the pandemic in 2021 were tested for neutralizing antibody to this virus by a standard plaque reduction neutralization assay. SARS-CoV-2 antibody was not detected in 40 deer sera samples collected during 2018, but 37% (20/54) samples collected in 2021 were positive for antibody. The seroprevalence rate between males and females differed significantly (

Indexed as

COVID-19DeerAnimalsAntibodies, NeutralizingAntibodies, ViralFemaleMaleSARS-CoV-2Seroepidemiologic StudiesTexasAntibodies, NeutralizingAntibodies, ViralantibodiesSARS-CoV-2Texaswhite-tailed deer

Identifiers

PMID34890284
PMCPMC8787703
OpenAlexW4200442741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.